Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Complete hydatidiform mole is a type of hydatiform mole characterized by abnormal hyperplastic trophoblasts and hydropic villi due to fertilization of an enucleated ovocyte by one or two haploid spermatozoa that can manifest with vaginal bleeding accompanied by nausea and frequent vomiting, hyperemesis gravidarum, risk of spontaneous miscarriage, hyperthyroidism, and has the potential of developing into choriocarcinoma.
Biomarker and diagnostic research for complete hydatidiform mole has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
79 publications have been identified in PubMed for complete hydatidiform mole. Research spans Case Report / Case Series (51%), Review / Meta-Analysis (14%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 40 | 51% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:12 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about complete hydatidiform mole
Research summaries |
11 |
14% |
Disease patterns and progression | 10 | 13% |
Testing and diagnosis research | 9 | 11% |
Laboratory research | 5 | 6% |
Clinical study results | 2 | 3% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Rivera-Hernández DA (2026). [PMID: 42096254](https://pubmed.ncbi.nlm.nih.gov/42096254/). *Rev Med Inst Mex Seguro Soc*. [Case Report / Case Series]
Salma Shabnam U (2026). [PMID: 41769489](https://pubmed.ncbi.nlm.nih.gov/41769489/). *Cureus*. [Diagnostic / Biomarker]
Salmeri N (2026). [PMID: 41066778](https://pubmed.ncbi.nlm.nih.gov/41066778/). *Ultrasound Obstet Gynecol*. [Review / Meta-Analysis]
Glaser R (2026). [PMID: 41694925](https://pubmed.ncbi.nlm.nih.gov/41694925/). *Cureus*. [Case Report / Case Series]
Xiang Y (2026). [PMID: 41438621](https://pubmed.ncbi.nlm.nih.gov/41438621/). *Case Rep Womens Health*. [Case Report / Case Series]
Feist H (2026). [PMID: 41524957](https://pubmed.ncbi.nlm.nih.gov/41524957/). *Pathologie (Heidelb)*. [Review / Meta-Analysis]
Schoenen S (2026). [PMID: 41780336](https://pubmed.ncbi.nlm.nih.gov/41780336/). *Int J Gynecol Cancer*. [Epidemiology / Natural History]
Qin Y (2026). [PMID: 42048630](https://pubmed.ncbi.nlm.nih.gov/42048630/). *Int J Gynecol Pathol*. [Case Report / Case Series]
Benn P (2026). [PMID: 41299888](https://pubmed.ncbi.nlm.nih.gov/41299888/). *Ultrasound Obstet Gynecol*. [Diagnostic / Biomarker]
Fayisa S (2026). [PMID: 41675068](https://pubmed.ncbi.nlm.nih.gov/41675068/). *Radiol Case Rep*. [Case Report / Case Series]
AI-curated news mentioning complete hydatidiform mole
Updated Apr 20, 2026
A recent case report details a postmenopausal woman diagnosed with a complete hydatidiform mole, contributing to the understanding of this rare condition. The findings may help inform future research and clinical approaches to similar cases.
A case report highlights a rare occurrence of complete hydatidiform mole coexisting with a live fetus, presenting significant maternal health risks. This comprehensive literature review adds to the understanding of this complex pregnancy condition.